Newron Pharmaceuticals Revenue

In the year 2024, Newron Pharmaceuticals had annual revenue of 51.39M EUR with 467.41% growth. Newron Pharmaceuticals had revenue of 47.98M in the half year ending December 31, 2024, with 1,370.07% growth.

Revenue

51.39M EUR

Revenue Growth

+467.41%

P/S Ratio

3.13

Revenue / Employee

2.34M EUR

Employees

Market Cap

150.91M CHF

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	51.39M	42.33M	467.41%
Dec 31, 2023	9.06M	2.96M	48.62%
Dec 31, 2022	6.09M	332.00K	5.76%
Dec 31, 2021	5.76M	504.00K	9.59%
Dec 31, 2020	5.26M	-1.78M	-25.29%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Roche Holding AG	63.49B
Novartis AG	43.89B
Lonza Group AG	7.09B
Alcon	8.77B
Galderma Group AG	3.73B
Sandoz Group AG	8.42B
Straumann Holding AG	2.50B
Sonova Holding AG	3.87B

Revenue Rankings

Newron Pharmaceuticals News

4 months ago - Newron Pharmaceuticals reports FY results - Seeking Alpha

More News